Interesting19 Jun 2018 20:44
Have no holdings here but I intend to buy sometime in the next week or so. I feel for holders as I feel that this stock has been the victim of fact bending and fear spreading. The RNS was very positive a few days ago. They stopped commercialisation? Why wouldn’t they? They are going through cash preservation why would they want extra costs? Also, the RNS proved that the science behind the drug works but that there may be a problem with administering the drug or dosage. Maybe slightly too far fetched but 48 is half of 96 which could explain a possible dosage error through communication error. This is now around cash level. This should be the floor. But who knows?